Products

EMARKETER delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
PRO+
New data sets, deeper insights, and flexible data visualizations.
Learn More
Reports
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Forecasts
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Charts
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Briefings
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About EMARKETER

Our goal is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Events
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Podcasts
Tune in to EMARKETER's daily, weekly, and monthly podcasts.
Learn More

Hard times ahead for D2C healthcare marketers

The “news”: 2022 was a bad year for venture capital investments in digital health, per Rock Health.

  • Total funding in US-based digital health startups amounted to $15.3 billion across 572 deals, just over half of 2021’s record $29.3 billion.
  • Still, it was more than 2020’s $14.7B total.

What it means: The report lays out the ramifications of VC investors’ switch to backing early stage health companies at the expense of growth- and late-stage ones.

Those moves have swelled the ranks of startups trying to gain more stable toeholds in the healthcare ecosystem. That has increased competition with growth-stage companies that aren’t able to access capital like they could in 2021 and early 2022.

Rock Health predicts that “macro headwinds for D2C won’t be relenting” in 2023. Some digital health companies will—or already have—switched to B2B sales to bolster their bottom lines. Others will succumb to the continuing economic pressures by shutting down or being acquired.

The knives are out: We’ve already laid out some issues digital health companies face in 2023, particularly those targeting consumers and/or health systems. Marketing budgets are under extra-sharp scrutiny for all media, including digital ad spending.

  • Advertisers that can afford to keep spending, will. D2C company Hims & Hers used that strategy through 2022 and heading into 2023.
  • Companies that pull back or stop spending will find themselves slipping further behind rivals that don’t. And it will be even harder to make up the lost market share when, or if, they return to the market.

Where digital ad dollars are going now: We estimate healthcare and pharma digital ad budgets will keep growing over the next few years, reaching nearly $20 billion in 2024.

New outlets are opening up: Retail media networks are still largely untested and, depending on the retailer, can be hard to navigate or prohibitively expensive. But D2C healthcare and pharma brands may find some success partnering with Best Buy, CVS Health, Kroger, or Walmart to break through the noise in other channels.

This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.